We randomly assigned 436 patients with acute ST-elevation myocardial infarction to ( 1 ) bare-metal stent without tirofiban , ( 2 ) bare-metal stent with tirofiban , ( 3 ) paclitaxel-eluting stent without tirofiban , and ( 4 ) paclitaxel-eluting stent with tirofiban .
